Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling

Chemico-Biological Interactions

Volumn 228, Issue , 2015, Pages 100-107

  Lu, Ying ^a   Ma, Wei ^a   Mao, Jun ^a   Yu, Xiaotang ^a   Hou, Zhenhuan ^a   Fan, Shujun ^a   Song, Bo ^a   Wang, Huan ^a   Li, Jiazhi ^a   Kang, Le ^a   Liu, Pixu ^a   Liu, Quentin ^a   Li, Lianhong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast carcinoma MCF 7; Cancer stem cells; Hedgehog signaling; Salinomycin

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; CD24 ANTIGEN; GLI1 PROTEIN, HUMAN; HERMES ANTIGEN; PHARMACOLOGY; PYRAN DERIVATIVE; SALINOMYCIN; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI1;

ANTAGONISTS AND INHIBITORS; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL LINE; CANCER INHIBITION; CANCER STEM CELL; CELL LEVEL; CELL PROLIFERATION; CELL SUBPOPULATION; CHEMICAL STRUCTURE; CHEMISTRY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; DRUG SCREENING; HUMAN; HUMAN CELL; MCF 7 CELL LINE; METABOLISM; METASTASIS INHIBITION; PATHOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE; TUMOR INVASION;

ANTAGONISTS AND INHIBITORS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EFFECTS; DRUG SCREENING ASSAYS, ANTITUMOR; HEDGEHOG PROTEINS; HUMANS; MCF-7 CELLS; METABOLISM; MOLECULAR STRUCTURE; NEOPLASTIC STEM CELLS; PATHOLOGY; PHARMACOLOGY; PYRANS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ERINACEIDAE;

EID: 84964297952     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.12.002     Document Type: Article

References (50)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J. Clin. 63 1 2013 11 30
2. C. Ginestier, M.H. Hur, and E. Charafe-Jauffret ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 5 2007 555S 567S
3. E. Charafe-Jauffret, C. Ginestier, and F. Iovino Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin. Cancer Res. 16 1 2010 45 55
4. R. Pardal, M.F. Clarke, and S.J. Morrison Applying the principles of stem-cell biology to cancer Nat. Rev. Cancer 3 12 2003 895 902
5. V. Clement, P. Sanchez, and N. De Tribolet HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity Curr. Biol. 17 2 2007 165 172
6. R. Gangemi, L. Paleari, and A.M. Orengo Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance Curr. Med. Chem. 16 14 2009 1688 1703
7. M.A. Velasco-Velázquez, N. Homsi, and M. De La Fuente Breast cancer stem cells Int. J. Biochem. Cell Biol. 44 4 2012 573 577
8. P.B. Gupta, T.T. Onder, and G. Jiang Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 4 2009 645 659
9. high stem-like cells on gastric cancer Biomed. Pharmacother. 65 7 2011 509 515
10. L. He, F. Wang, and W.Q. Dai Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines Pancreatology 13 1 2013 72 78
11. F. Wang, L. He, and W.Q. Dai Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo PLoS ONE 7 12 2012 e50638
12. B. Zhang, X. Wang, and F. Cai Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK Tumor Biol. 33 6 2012 1855 1862
13. K. Ketola, M. Hilvo, and T. Hyötyläinen Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress Br. J. Cancer 106 1 2012 99 106
14. A. Scherzed, S. Hackenberg, and K. Froelich Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro Toxicol. Lett. 218 3 2013 207 214
15. D. Fuchs, A. Heinold, and G. Opelz Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells Biochem. Biophys. Res. Commun. 390 3 2009 743 749
16. D. Fuchs, V. Daniel, and M. Sadeghi Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells Biochem. Biophys. Res. Commun. 394 4 2010 1098 1104
17. R. Riccioni, M.L. Dupuis, and M. Bernabei The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor Blood Cells Mol. Dis. 45 1 2010 86 92
18. Y. Wang Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells Med. Chem. 7 2 2011 106 111
19. J.H. Kim, H.I. Yoo, and H.S. Kang Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest Biochem. Biophys. Res. Commun. 418 1 2012 98 103
20. W.K. Kim, J.H. Kim, and K. Yoon Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest Invest. New Drugs 30 4 2012 1311 1318
21. J.H. Kim, M. Chae, and W.K. Kim Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein Br. J. Pharmacol. 162 3 2011 773 784
22. Q.L. Tang, Z.Q. Zhao, J.C. Li, Y. Liang, J.Q. Yin, and C.Y. Zou Salinomycin inhibits osteosarcoma by targeting its tumor stem cells Cancer Lett. 11 2011 13 121
23. J. Mao, S. Fan, and W. Ma Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment Cell Death Dis. 5 2014 e1039
24. A. Huczynski Salinomycin - a new cancer drug candidate Chem. Biol. Drug Des. 79 3 2012 235 238
25. M. Al-Hajj, M.S. Wicha, and A. Benito-Hernandez Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. 100 7 2003 3983 3988
26. C. Ginestier, M.H. Hur, and E. Charafe-Jauffret ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 5 2007 555 567
27. G. Dontu, W.M. Abdallah, and J.M. Foley In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev. 17 10 2003 1253 1270
28. P.A. Beachy, S.S. Karhadkar, and D.M. Berman Tissue repair and stem cell renewal in carcinogenesis Nature 432 7015 2004 324 331
29. N. Takebe, P.J. Harris, and R.Q. Warren Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways Nat. Rev. Clin. Oncol. 8 2 2010 97 106
30. V. Tirino, V. Desiderio, F. Paino, A.D. Rosa, F. Papaccio, and M.L. Noce Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization FASEB J. 27 2013 13 24
31. M. Diehn, R.W. Cho, and N.A. Lobo Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 7239 2009 780 783
32. L.V. Nguyen, R. Vanner, and P. Dirks Cancer stem cells: an evolving concept Nat. Rev. Cancer 12 2 2012 133 143
33. M. Antoszczak, E. Maj, and J. Stefańska Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin Bioorg. Med. Chem. Lett. 24 7 2014 1724 1729
34. M. Mitani, T. Yamanishi, and Y. Miyazaki Salinomycin effects on mitochondrial ion translocation and respiration Antimicrob. Agents Chemother. 9 4 1976 655 660
35. D. Lu, M.Y. Choi, and J. Yu Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells Proc. Natl. Acad. Sci. 108 32 2011 13253 13257
36. J. Lee, S. Kotliarova, and Y. Kotliarov Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines Cancer Cell 9 5 2006 391 403
37. Z.F. Ning, Y.J. Huang, and T.X. Lin Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24 J. Int. Med. Res. 37 3 2009 621 630
38. J. Dou, M. Pan, and P. Wen Isolation and identification of cancer stem-like cells from murine melanoma cell lines Cell. Mol. Immunol. 4 6 2007 467 472
39. A.K. Croker, D. Goodale, and J. Chu High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J. Cell Mol. Med. 13 8b 2009 2236 2252
40. G. Feldmann, S. Dhara, and V. Fendrich Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers Cancer Res. 67 5 2007 2187 2196
41. T.L. Lin Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926 PLoS ONE 5 2010 e15262
42. C. Dierks, R. Beigi, and G.R. Guo Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation Cancer Cell 14 3 2008 238 249
43. C. Wicking, and E. McGlinn The role of hedgehog signalling in tumorigenesis Cancer Lett. 173 1 2001 1 7
44. L. Ruel, R. Rodriguez, and A. Gallet Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog Nat. Cell Biol. 5 10 2003 907 913
45. M.T. Lewis Hedgehog signaling in mouse mammary gland development and neoplasia J. Mammary Gland Biol. Neoplasia 6 1 2001 53 66
46. M. Kubo, M. Nakamura, and A. Tasaki Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer Cancer Res. 64 17 2004 6071 6074
47. J. Jiang, and C. Hui Hedgehog signaling in development and cancer Dev. Cell 15 6 2008 801 812
48. D. Zhang, L. Cao, and Y. Li Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy World J. Surg. Oncol. 11 2013 25
49. G.K. Malhotra, X. Zhao, H. Band, and V. Band Shared signaling pathways in normal and breast cancer stem cells J. Carcinog. 10 2011 38
50. S. Nagai, M. Nakamura, and K. Yanai Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation Cancer Sci. 99 7 2008 1377 1384